#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Isodicentric chromosome 15 syndrome Diffuse large B-cell lymphoma refractory Thalassaemia alpha Mucous membrane pemphigoid Autoimmune myositis Cluster headache Pancreatic neuroendocrine tumour Angiosarcoma metastatic Mantle cell lymphoma recurrent Glycogen storage disease type V Primary immunodeficiency syndrome Desmoid tumour Immunodeficiency congenital Hepatitis B Castleman's disease More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria – Basic Information Biotinidase deficiency – Trials in Disease IgA nephropathy – Treatment Focal segmental glomerulosclerosis – Trials in Disease Cytokine release syndrome Loeys-Dietz syndrome – Diagnostics Lysosomal storage disorder – Life with Disease Congenital hypotransferrinaemia – Basic Information Burkitt’s lymphoma Pituitary-dependent Cushing’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nefopam Hydrochloride Tafluprost Clonazepam Carisbamate RUBIDIUM CHLORIDE Cefoxitin Sodium Cefaclor Emicizumab Sodium Alginate Hypothalamic Phospholipids Dornase Alfa Suvecaltamide Tirbanibulin Opevesostat MAGNESIUM CARBONATE HEAVY Pemetrexed Diacid Monohydrate TALADEGIB Fludrocortisone Acetate Glycopyrronium Bromide Gallium (68Ga) More therapies…

    Learn about Your Condition

    Nodal osteoarthritis Peritoneal dialysis Osteochondrodysplasia Rectal adenocarcinoma Dengue fever Angiosarcoma Carpal tunnel syndrome Angina pectoris Eosinophilic oesophagitis Spermatocele Migraine with aura Oesophageal food impaction Cardiac failure chronic ROHHAD syndrome Mucosal inflammation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • A study to compare how perampanel is absorbed in healthy adult men and women.

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Perampanel
    Czechia

  • Comparative Bioavailability of Inhaled Levodopa (Levodopa Cyclops) versus Inhaled Levodopa Powder with Carbidopa in Healthy Adults for Parkinson’s Disease

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Carbidopa
    • Levodopa
    Bulgaria

  • A study to compare the safety of ketamine hydrochloride and esketamine in healthy men for the treatment of depression

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Ketamine Hydrochloride
    Germany

  • A study to compare how the body absorbs perampanel in healthy adult men and women during fasting conditions

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Perampanel
    Czechia

  • Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetapir (18F)
    • Flutemetamol (18F)
    • TRONTINEMAB
    Denmark France Germany Italy The Netherlands Poland +1

  • A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    France Germany Italy Poland Spain
Previous Page
1 … 80 81 82 83 84 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!